B-cell deficiency suppresses vaccine-induced protection against murine filariasis but does not increase the recovery rate for primary infection.
about
Of mice, cattle, and humans: the immunology and treatment of river blindnessThe subcutaneous movements of filarial infective larvae are impaired in vaccinated hosts in comparison to primary infected hosts.A comprehensive, model-based review of vaccine and repeat infection trials for filariasisFilarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancyLack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infectionNeutropenic Mice Provide Insight into the Role of Skin-Infiltrating Neutrophils in the Host Protective Immunity against Filarial Infective LarvaeResistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactionsMigratory phase of Litomosoides sigmodontis filarial infective larvae is associated with pathology and transient increase of S100A9 expressing neutrophils in the lung.Cofactor independent phosphoglycerate mutase of Brugia malayi induces a mixed Th1/Th2 type immune response and inhibits larval development in the hostIn a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infectionPrimed peritoneal B lymphocytes are sufficient to transfer protection against Brugia pahangi infection in mice.To B or not to B: B cells and the Th2-type immune response to helminths.The human parasite Loa loa in cytokine and cytokine receptor gene knock out BALB/c mice: survival, development and localization.Granulocytes in helminth infection -- who is calling the shots?Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function?Immunomodulation by filarial nematodes.The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.Basophils help establish protective immunity induced by irradiated larval vaccination for filariasisFat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammationInterleukin-10 (IL-10) counterregulates IL-4-dependent effector mechanisms in Murine Filariasis.Co-infection restrains Litomosoides sigmodontis filarial load and plasmodial P. yoelii but not P. chabaudi parasitaemia in mice.Future prospects and challenges of vaccines against filariasis.Immunization with Brugia malayi Hsp70 protects mice against Litomosoides sigmodontis challenge infection.Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae.Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.Chronic helminth infection burden differentially affects haematopoietic cell development while ageing selectively impairs adaptive responses to infection.Adult Brugia malayi mitochondrial and nuclear fractions impart Th1-associated sizeable protection against infective larval challenges in Mastomys coucha.
P2860
Q21144551-C52CB7EE-6953-4C22-97F6-8B304EF7B218Q24813580-951BB83E-B349-473E-89B9-77EF527710F9Q27000517-F5A6C56A-17CD-41C5-B7D3-66204D56D0E9Q28475846-8CE439DF-FB26-41B1-ACBA-780D4978406BQ28513995-BDE7E211-8DE4-456C-B31C-51CC06D3395EQ28551578-0671D5F7-03CC-416C-947D-63E79AB01113Q31028656-D809EDC6-C524-44CF-ADD2-38E7583E8CD5Q33708053-4F33B3BB-52CA-4BBD-92FD-F2A9476D6C6CQ33908711-42C8B927-D716-48DA-8B44-A109C11F3285Q34596221-AA703055-D157-4398-B9BA-3853B0F7D23FQ34629159-78745090-A6A8-4CCE-9240-AB1E8CC13C41Q34714972-1417DC72-28B6-4081-8AE3-E48FAD5F0529Q34792884-1AEB3FB2-466A-4C3C-A55F-B7A628047D89Q35834225-86395B73-49D7-486B-A404-C60ACF474788Q36088115-2844345D-06A1-4D9C-9666-728CDD5CAB1AQ36239677-3D722108-E850-4830-9E01-3ED2AADFD358Q36265018-1F8C1556-5A4E-4B42-BD67-D245C033A877Q36599857-EFF326DE-EA72-4E92-8F14-512E06315420Q37069045-830D1268-8A27-4852-844B-15B20E8082E0Q37260893-C646B2C6-8DE3-46A9-90F7-D69E0768C9D3Q37582805-38B9E62A-BA41-4868-A911-18796CA54099Q37693547-F306B3A8-4EAC-4F98-86B0-1E701A741195Q37965765-C8B97007-7564-4736-882A-DE5EA979FA12Q39051597-C8483809-1737-41F0-837E-8549C7D48240Q40469874-F2135B97-986C-456A-B498-656D59F768F8Q43088896-43CE2841-C9E3-4407-B590-B399919D4997Q50421498-E2FA33D7-C6B9-41DB-B91D-F1E4034DA95FQ53432918-1D22C678-37DE-4045-B974-4382156F6C00
P2860
B-cell deficiency suppresses vaccine-induced protection against murine filariasis but does not increase the recovery rate for primary infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
B-cell deficiency suppresses v ...... ry rate for primary infection.
@ast
B-cell deficiency suppresses v ...... ry rate for primary infection.
@en
type
label
B-cell deficiency suppresses v ...... ry rate for primary infection.
@ast
B-cell deficiency suppresses v ...... ry rate for primary infection.
@en
prefLabel
B-cell deficiency suppresses v ...... ry rate for primary infection.
@ast
B-cell deficiency suppresses v ...... ry rate for primary infection.
@en
P2093
P2860
P1476
B-cell deficiency suppresses v ...... ry rate for primary infection.
@en
P2093
P2860
P304
P356
10.1128/IAI.69.11.7067-7073.2001
P407
P577
2001-11-01T00:00:00Z